Title : Menière's disease: combined pharmacotherapy with betahistine and the MAO-B inhibitor selegiline-an observational study.

Pub. Date : 2018 Oct

PMID : 29532287






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Meniere"s disease: combined pharmacotherapy with betahistine and the MAO-B inhibitor selegiline-an observational study. Selegiline monoamine oxidase B Homo sapiens
2 CONCLUSIONS: The achievement of the same clinical effect with a significantly lower (about 1/5) dosage of betahistine can be explained by the inhibition of the MAO-B by selegiline leading to higher serum concentrations of betahistine. Selegiline monoamine oxidase B Homo sapiens